Bayer posts strong Q1 2026 results as Crop Science surge lifts earnings & outlook
Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros
Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros
Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
The accrued data from the Phase 3 study suggest that the baseline characteristics of the enrolled patients are consistent with those observed in previous studies
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Advanced image-free robotic platform to support greater precision, personalised planning, and improved patient outcomes
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors
Subscribe To Our Newsletter & Stay Updated